Acute Pain Epidemiology Forecast 2024-2032

Acute Pain Epidemiology Forecast Report Coverage

Expert Market Research's “Acute Pain Epidemiology Forecast Report 2024-2032” offers comprehensive information on the prevalence and demographics of acute pain. It projects the future incidence and prevalence rates of acute pain across various populations. The study covers age, gender, and type as major determinants of the acute pain-affected population. The report highlights patterns in the prevalence of acute pain over time and projects future trends based on multiple variables.

Acute Pain Disease Overview

Acute pain is characterized by an abrupt onset of discomfort, usually due to an injury, surgery, or inflammation. It has a vital biological function in alerting the body to harmful stimuli. This kind of pain is typically incidental, lasting anywhere from a few seconds to several weeks, and it's frequently linked to incidents like infections, surgeries, or accidents. Acute pain can cause a variety of sensations, such as stabbing, throbbing, or sharp pain. It is also frequently accompanied by physical symptoms in the affected area, such as heat, redness, and swelling.

Acute pain is primarily caused by the activation of nociceptors, which are specialized sensory neurons that react negatively to stimuli. The central nervous system receives these signals, processes, and interprets them to produce the sensation of pain.

Acute Pain: Treatment Overview

A comprehensive approach is used to treat acute pain. Medicinal options include acetaminophen for general pain relief, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen for mild to moderate pain, and opioids like morphine for more severe pain. Pain management techniques that do not involve drugs, like massage, ice and heat packs, physical therapy, and cognitive behavioural therapy, can also be very effective. Furthermore, targeted relief for conditions may be obtained through interventional procedures such as trigger point injections and nerve blocks. When multiple therapies are used to improve pain relief while reducing the need for opioids and their negative effects, a multimodal approach frequently produces the best results.

Epidemiology

The acute pain epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for acute pain by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for acute pain and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to National Health Institute, an estimated 25.3 million adults experienced pain on daily basis. Approximately 15% of adults, or nearly 40 million people, suffer from severe pain. Severe pain sufferers are also more likely to be in worse health.
• According to BMC Geriatrics, an estimated 37% of middle-aged and older Indians reported experiencing pain on a regular basis. The prevalence of pain rises with age and is higher in older adults (75 years of age and above).
• The Global Burden of Disease Study 2019 states that headache and low back pain disorders rank among the top 10 causes of Disability-Adjusted Life Years (DALY) for three age groups including 10–24 years, 25–49 years, and 50–74 years.
• According to a review by Gregory and McGowan (2016), up to 84% of adult hospital patients reported experiencing acute pain.

Country-wise Acute Pain Epidemiology

The acute pain epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of acute pain differs between nations and areas because of factors such as the availability of pain management treatments, socioeconomic status, healthcare infrastructure, and cultural perspectives on pain. In the United States, acute pain affects 20% of the general population.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options and classification/types of acute pain based on several factors.
• Acute Pain Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India)
• The report helps to identify the patient population, the unmet needs of acute pain are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of acute pain epidemiology in the 8 major markets?
• What will be the total number of patients with acute pain across the 8 major markets during the forecast period?
• What was the country-wise prevalence of acute pain in the 8 major markets in the historical period?
• Which country will have the highest number of acute pain patients during the forecast period of 2024-2032?
• Which key factors would influence the shift in the patient population of acute pain during the forecast period of 2024-2032?
• What are the currently available treatments for acute pain?
• What are the disease risks, signs, symptoms, and unmet needs of acute pain?

Related Reports

• Acute Pain Drug Pipeline Analysis Report 2024
• Acute Pain Market Report and Forecast 2024-2032